ATLAS-1 (Completed)
Anti-Xa Therapy to Lower cardiovascular
events in addition to Aspirin with or without thienopyridine therapy in Subjects with Acute Coronary Syndrome
- Medicine
- rivaroxaban
- Population
- ASCVD
- Phase
- II
- Starting year
- 2001
- More information
- ClinicalTrials.gov